Tokyo, Japan

Hiroshi Naganawa


Average Co-Inventor Count = 6.1

ph-index = 7

Forward Citations = 151(Granted Patents)


Location History:

  • Tokyo, JA (1977)
  • Denenchohushi, JP (1980)
  • Honmachi, JP (1983 - 1985)
  • Tokyo, JP (1978 - 2007)

Company Filing History:


Years Active: 1977-2007

Loading Chart...
34 patents (USPTO):

Title: Hiroshi Naganawa: Pioneer in Antibiotic Innovations

Introduction

Hiroshi Naganawa, based in Tokyo, Japan, is a renowned inventor with an impressive portfolio of 34 patents. His work primarily focuses on antibiotics, contributing significantly to advancements in medical research and pharmaceutical applications.

Latest Patents

Among his notable patents are the groundbreaking antibiotics, tripropeptins, including the innovative process for producing such compounds. The tripropeptins, represented by a general formula, are developed using a unique culture process. These antibiotics exhibit remarkable antibacterial activities against various bacterial infections, including drug-resistant strains like methicillin-resistant and vancomycin-resistant strains. Additionally, his research extends to compositions for treating malaria, notably the antibiotic SF2487, which shows promising antimalarial activity against the proliferation of malarial parasites.

Career Highlights

Hiroshi Naganawa has made significant contributions to microbial chemistry through his work with prominent organizations such as the Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai and the Microbial Chemistry Research Foundation. His innovative spirit and dedication have positioned him at the forefront of antibiotic research and development.

Collaborations

Throughout his career, Naganawa has collaborated with esteemed colleagues, including Tomio Takeuchi and Masa Hamada. These partnerships have fostered an environment of creativity and shared expertise, further advancing the field of antibiotic research.

Conclusion

Hiroshi Naganawa's extensive body of work in the field of antibiotics demonstrates his commitment to innovation and research. His patents continue to impact the pharmaceutical industry, paving the way for effective treatments against bacterial and parasitic infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…